Deca Durabolin Amp 50MG 1ML

Deca-Durabolin Amp 50MG 1ML
Deca Durabolin
DecaDurabolin
nandrolone decanoate
If you require a prescription, please visit our online doctor

Deca-Durabolin Amp 50MG 1ML: For use in osteoporosis in post-menopausal women
If you require a prescription, please visit our online doctor

Therapeutic indications
For use in osteoporosis in post-menopausal women.

Established osteoporosis should have been diagnosed by the following

parameters:

i) crush or wedge fractures of the vertebrae

ii) other osteoporotic fractures

iii) established reduction in bone mineral content as measured by accepted BMC measurements.

Posology and method of administration
Dosage

Post-menopausal women

50 mg every three weeks.

The duration of treatment depends on the clinical response and the possible occurrence of side-effects.

We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.


Children

There are no recommendations for use in children.



Administration

Deep intramuscular injection

Contraindications
Pregnancy

Breast-feeding

Porphyria

Allergies to any of the components

Known or suspected carcinoma of prostate or mammary carcinoma in the male

Special warnings and precautions for use
If signs of virilisation develop, discontinuation of the treatment should be considered.

Patients, especially the elderly, with the following conditions should be monitored:

' latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine (or a history of these conditions), since anabolic steroids may occasionally induce sodium and water retention;

' incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure;

' skeletal metastases, since anabolic steroids may induce hypercalcaemia and hypercalciuria in these patients;

' liver dysfunction - caution should be used in patients with severe hepatic impairment and Deca Durabolin 50mg/ml should only be used if the benefits outweigh the risks.

' diabetes mellitus


Deca Durabolin 50mg/ml contains Arachis oil (peanut oil) and should not be taken / applied by patients known to be allergic to peanut. As there is a possible relationship between allergy to peanut and allergy to Soya, patients with Soya allergy should also avoid Deca Durabolin 50mg/ml.

Interaction with other medicinal products and other forms of interaction
Anabolic steroids may improve glucose tolerance and decrease the need for insulin or other antidiabetic drugs in diabetics

Pregnancy and lactation
Deca-Durabolin is contra-indicated during pregnancy because of possible masculinisation of the foetus. There are insufficient data on the use of this medicine during breast-feeding to assess potential harm to the infant or a possible influence on milk production.

Undesirable effects
Deca-Durabolin at the recommended dosages is unlikely to produce virilising effects. High dosages, prolonged treatment and/or too frequent administration may cause:

' Virilisation which appears in sensitive women as hoarseness, acne, hirsutism and increase of libido; in prepubertal boys as an increased frequency of erections and phallic enlargement, and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change which may end in long-lasting, sometimes irreversible deepening of the voice;

' Amenorrhoea and inhibition of spermatogenesis;

' Premature epiphyseal closure;

' Sodium and water retention.


Abnormal liver function tests have been reported in patients treated with (high doses) of Deca-Durabolin.

Liver tumours have been reported occasionally on prolonged treatment with orally active C17-alpha alkylated anabolic steroids. A relationship between liver tumours and non-C17-alkylated injectable steroids, such as nandrolone esters, appears to be highly unlikely, but cannot be absolutely excluded.